Lysogene Pushes Forward With Sanfilippo Syndrome Study, Establishes Footprint in U.S. Post author:Sam Post published:October 24, 2017 Post category:BioPharma Finding a treatment for Sanfilippo Syndrome is a personal matter for the Lysogene team. Source: BioSpace You Might Also Like Syros Pharma To Present Biomarker Data From Ongoing Phase 2 Clinical Trial Of SY-1425 At Conference On AML September 28, 2017 With Plans for U.S. and China Manufacturing Plants, Athenex Gears Up for $100 Million IPO May 15, 2017 Eli Lilly to Invest $72M in Indianapolis Diabetes Manufacturing October 22, 2017
Syros Pharma To Present Biomarker Data From Ongoing Phase 2 Clinical Trial Of SY-1425 At Conference On AML September 28, 2017
With Plans for U.S. and China Manufacturing Plants, Athenex Gears Up for $100 Million IPO May 15, 2017
